Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis-Reference-Cited by-同舟云学术

Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis

Published:2017-03-20 Issue:7 Volume:26 Page:997-1004
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Steeples Laura R.¹²,Anand Nitin³,Moraji Jiten¹,Jones Nicholas P.¹²

Affiliation:

1. Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

2. University of Manchester, Manchester, UK

3. Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire Royal Hospital, Gloucester, UK

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2017.1294185

Reference38 articles.

1. Causes and frequency of blindness in patients with intraocular inflammatory disease.

2. Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema

3. Periocular Corticosteroid Injections in Uveitis